source
- FDA begins review of Roche’s experimental multiple sclerosis pill fenebrutinibThe FDA has accepted Roche's application for fenebrutinib, an experimental oral therapy for multiple sclerosis, and has started a priority review. The review will evaluate the drug in both relapsi…
- PhRMA appoints former congressman Eric Cantor as CEO as Pierre Fabre resubmits Ebvallo approval requestPhRMA announced that former U.S. House member Eric Cantor will become its president and chief executive on Nov 9, taking over from longtime leader Steve Ubl. Cantor served Virginia from 2000 to 201…